Media

In the latest episode of ‘Newton’, the education program on the Italian television channel Rai Scuola, the focus is on skin – the largest organ of the human body. As a guest on the program Daniela Marino talks about the advances CUTISS is making in bioengineering personalized human skin tissue for patients suffering from severe skin burns and injuries. Skip ahead to the 38min mark to see and hear Daniela speak. Newsroom Interview

More than a year since CUTISS announced the world’s first machine to bioengineer human skin, the news continues to generate interest and excitement. As part of their program focused on Swiss innovation, the broadcaster RTS (Neuchatel) visited CUTISS and CSEM who helped develop the denovoCast machine, to find out how automation can scale-up the production of bioengineered skin tissue. Newsroom Link to reportage

The October issue of PwC Switzerland’s ceo magazine is dedicated to the topic of courage. The courage to make decisions, and the courage to set out on the path of entrepreneurship. Our CEO Daniela was interviewed for this edition where she talked about setting up CUTISS, her ambitions, calculated risks, and outcomes for patients suffering from severe burns. What hurdles did Daniela have to overcome? Read on to find out: here Newsroom Interview

The Tribune de Côte d’Azur covered the first ‘Impact Awards’ 2022, a jury-led competition organized by Team Côte d’Azur that recognizes leading companies of the local economic ecosystem. CUTISS Innovation, our French subsidiary, was honored to win the ‘Innovation’ trophy for continued innovation and research into regenerative medicine and skin pigmentation. Our director Cécile Cousin was there to receive the award, while our CIO Vincent Ronfard gave an interview to the Tribune newspaper, providing some insights into what our Innovation lab will focus on. Newsroom Interview

As part of the 25th anniversary celebrations of >>venture>>, Daniela contributed an opinion piece on how we can better nurture startups in Switzerland. Newsroom article le matin dimanche (French)

The Swiss daily business newspaper Agefi published an interview with our CEO Daniela Marino following the announcement that CUTISS started onsite denovoSkin production, at its very own GMP facility. This is an exciting milestone for the company, resulting in greater production flexibility and scale-up opportunities. Newsroom Link to Interview

The popular French science magazine Sciences et Avenir has published an article explaining the science behind our denovoSkin and denovoCast innovations, and the promise that this brings to patients suffering from severe skin burns and injuries. The journalist had visited CUTISS to see this for herself and to speak with our CEO Daniela and CIO Vincent. “Swiss researchers have succeeded in automating the manufacture of autologous skin, produced from the patient’s own cells. An innovation that will benefit burn victims in the future. Reportage from the laboratory of this promising start-up near Zurich, Switzerland.” The article was also published in the monthly edition of the magazine, February 2022. Newsroom Link to article

Swiss national television RTS came to CUTISS recently to find out about the denovoSkin, and to hear from our CIO Vincent about the promising potential of automation to scale up skin tissue bioengineering. The CUTISS segment was broadcast as part of RTS’s business program T.T.C. (Toutes taxes comprises) and is available on playback (in French) using the link below. https://www.youtube.com/watch?v=fK0Nmza1ECs Newsroom LInk to program

The Swiss national television channel RSI La 1 recently came to our offices to take a closer look at our work to develop denovoSkin, the personalized, bioengineered skin graft for children and adults suffering from large skin defects, such as severe burns. The interview with Daniela Marino was part of their monthly program Come va?, the popular science show exploring current health and medical topics, and this month’s episode focused on our body’s largest organ: skin. The episode is available on playback (in Italian) with the link below. Newsroom LInk to episode

As part of the journal’s “Innovations in wound care” section, the latest edition features a guest editorial by our CEO Daniela Marino and CIO Vincent Ronfard. When patients suffer from large and severe skin injuries affecting more than 50% of the body, such as burns, then the current standard of care – autografting – presents real challenges. New approaches to bioengineering skin could change the paradigm for large burn treatment. But even so, other challenges remain, such as mainly manual, time-consuming and costly production. Our authors put forward that automation is the answer, meeting three key objectives: reduction in manufacturing time, improved skin graft quality and safety, and decreased costs. CUTISS has developed the denovoSkin, an autologous bioengineered dermo-epidermal skin graft, intended to provide permanent skin coverage with minimal scarring. It is currently in phase II clinical trials, and is manufactured manually in a fully equipped cleanroom by highly skilled personnel. The future of denovoSkin is the automation of its manufacturing process, and CUTISS has already produced groundbreaking research and development grade prototypes for the automated production of denovoSkin. At this moment, CUTISS remains the industry pioneer in the automation of bioengineered skin manufacturing. Read the ARTICLE for further insights on the challenges and opportunities in regenerative medicine. Newsroom LInk to FULL Article